Dr. William G. Wierda, MD, PhD
- Medicare services, 2024
- 789
- Medicare patients, 2024
- 268
- Part D claims, 2024
- 249
- Publications
- 556
- Clinical trials
- 22
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Wierda's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. William G. Wierda is a hematologist and oncologist in Houston, Texas
Dr. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Wierda's NPI, 1497848279, was assigned on October 2, 2006. Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993. Dr. Wierda's Texas license number on file is L3873.
- NPI
- 1497848279NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0840488151
- NPI enumeration date
- October 2, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. William G. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. William G. Wierda is affiliated with 1 site of care and 1 medical group
Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. William G. Wierda's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wierda practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. William G. Wierda is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Wierda's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Wierda's licenses on file in 5 states: Texas, Florida, California, Oklahoma and North Carolina.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Florida license
- California license
- Oklahoma license
- North Carolina license
Clinical focus
Dmand AI lists anemia, chronic anemia, chronic leukemia, immune deficiency disease and lymphoma among the conditions Dr. Wierda treats.
Hematologists and oncologists near Dr. Wierda
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. William G. Wierda billed Medicare for 789 services in 2024
CMS data shows 789 Medicare services from Dr. Wierda across 5 procedure codes in 2024, for 268 Medicare patients. Medicare paid $78,513 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Wierda's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7282024: 7898%
Dr. Wierda compared with the Texas median for hematologists and oncologists, 2024
- Dr. Wierda
- Texas median
- Medicare services
- 789vs 1,16232% below
- Medicare patients
- 268vs 2517% above
- Part D claims
- 120vs 48975% below
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Wierda's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wierda?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wierda and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. William G. Wierda treated 268 Medicare patients in 2024, average age 74
CMS counts 268 Medicare patients who saw Dr. Wierda in 2024. The largest group is 65 to 74, with 127 patients. 73% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Wierda's median patient age at 72, with 47% women.
Dr. Wierda's Medicare patients by age, 2024
Dr. Wierda's Medicare patients by sex, 2024
- Women10539%
- Men16361%
Chronic conditions among Dr. Wierda's Medicare patients, 2024
- High blood pressure73%
- High cholesterol72%
- Arthritis45%
- Ischemic heart disease29%
- Chronic kidney disease28%
- Anxiety26%
- Atrial fibrillation25%
- Mood disorders24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Wierda's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. William G. Wierda wrote 249 Medicare Part D claims in 2024
In 2024, Dr. Wierda wrote 249 Medicare Part D claims for 86 patients. 75% of them were for generic drugs. CMS names the drug for 120 of them, across 6 drugs with 11 or more claims each, at $570,359 in total drug cost. In 2023, CMS named 138 claims across 5 drugs.
Dr. Wierda's Part D claims by kind of drug, 2024
- Generic186 claims75%
- Brand-name63 claims25%
Dr. Wierda's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Wierda's Part D claims, 2024
- Antibiotics22%54 of 249 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1382024: 12013%
Drugs named by CMS: 6 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. William G. Wierda scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wierda for performance year 2024, reported as part of a group. Dr. Wierda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Wierda's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. William G. Wierda has 556 publications on record
Dmand AI links 556 papers to Dr. Wierda, published from 2003 to 2025. 2017 was the busiest year, with 58. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Wierda has published most often in Blood. Dr. Wierda's most frequent co-authors are Michael J. Keating, MD, Susan M. O'Brien, MD and Hagop M. Kantarjian, MD.
Dr. Wierda's papers by year, 2016 to 2025
Topics Dr. Wierda writes about most
- Leukemia, Lymphocytic, Chronic, B-Cell
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Pyrimidines
- Antibodies, Monoclonal
- Rituximab
- Protein Kinase Inhibitors
- Piperidines
Dr. Wierda's most frequent co-authors
- Michael J. Keating, MD244 shared papers
- Susan M. O'Brien, MD180 shared papers
- Hagop M. Kantarjian, MD165 shared papers
Recent publications by Dr. Wierda
See who Dr. Wierda researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wierda works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. William G. Wierda has worked on 22 clinical trials
Dmand AI links Dr. Wierda to 22 clinical trials, 11 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Hematologic Neoplasms. M.D. Anderson Cancer Center sponsors the most, 15.
Clinical trials with Dr. Wierda by phase
- 8Phase 1: 8 trials
- 3Phase 1/2: 3 trials
- 11Phase 2: 11 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Wierda's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Hematologic Neoplasms
- Jacobs syndrome
- Leukemia, Prolymphocytic
Investigators on the most trials with Dr. Wierda
- Antonio Sergio Torloni, MD2 shared trials
- Adam Asch, MD1 shared trial
- Farrukh T. Awan, MD, MS1 shared trial
Recent clinical trials with Dr. Wierda
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. William G. Wierda received $124,245 in industry payments from 2016 to 2025
CMS Open Payments shows 265 general payments to Dr. Wierda from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 82% of the total. Abbvie Inc. paid the most, $72,901. It also lists 15 research payments totaling $39,254 from 2016 to 2020.
General payments to Dr. Wierda by program year, 2016 to 2025
General payments to Dr. Wierda by kind, 2016 to 2025
- Travel and lodging$101,94082%
- Speaker and faculty fees$12,04010%
- Food and beverage$8,1857%
- Honoraria$2,0002%
- Consulting fees$790%
Companies that paid Dr. Wierda the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. William G. Wierda's committees and leadership roles
Dr. Wierda's committees and leadership roles
- NCCN Guidelines Insights: Non-Hodgkin's Lymphomas Version 3.2016Panel Member
- 2016
Source: Dmand AI Professional Profile Data
Dr. William G. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science
Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. William G. Wierda accepts plans from 9 insurance carriers
Dr. Wierda is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Elevance
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- CMS Medicare
- +1 more carriersWith a free account
Plan types Dr. Wierda accepts, by number of carriers
- PPO6
- Medicare5
- POS5
- HMO4
- EPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. William G. Wierda's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. William G. Wierda
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. William G. Wierda's NPI number?
Dr. William G. Wierda's NPI number is 1497848279. It was assigned on October 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. William G. Wierda?
Dr. William G. Wierda is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. William G. Wierda practice?
Dr. Wierda practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. William G. Wierda's medical license number?
Dr. Wierda's Texas license number on file is L3873, one of the licenses on file in 5 states.
Which states has Dr. William G. Wierda been licensed in?
Dmand AI has state licenses on file for Dr. Wierda in Texas (2002 to 2025), Florida (since 2021), California (1996 to 2025), Oklahoma (2020 to 2021) and North Carolina (1993 to 1999).
Which hospitals is Dr. William G. Wierda affiliated with?
Dr. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. William G. Wierda part of?
Dr. Wierda is linked to Physicians Referral Service.
Does Dr. William G. Wierda accept Medicare?
Yes. CMS data shows Dr. Wierda billed Medicare for 789 services in 2024, and Dr. Wierda accepts Medicare assignment.
What is Dr. William G. Wierda's MIPS score?
Dr. Wierda's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. William G. Wierda see?
CMS counts 268 Medicare patients who saw Dr. Wierda in 2024, with an average age of 74.
Show 8 more questionsShow fewer questions
What services does Dr. William G. Wierda bill to Medicare?
In 2024, Dr. Wierda's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. William G. Wierda go to medical school?
Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993.
What drugs does Dr. William G. Wierda prescribe most?
In 2024 Medicare Part D data, Dr. Wierda's most prescribed drugs by claims were Venclexta, Valacyclovir and Calquence.
Has Dr. William G. Wierda received payments from drug or device companies?
CMS Open Payments shows $124,245 in general payments to Dr. Wierda from 17 companies from 2016 to 2025. The largest total came from Abbvie Inc.
How long has Dr. William G. Wierda been practicing?
Dr. Wierda graduated from medical school in 1993, 33 years ago.
Does Dr. William G. Wierda do research?
Dmand AI links 556 publications to Dr. Wierda, published from 2003 to 2025. Dr. Wierda has worked on 22 clinical trials.
Who does Dr. William G. Wierda publish with?
Dr. Wierda's most frequent co-authors are Michael J. Keating, MD (244 shared papers), Susan M. O'Brien, MD (180 shared papers) and Hagop M. Kantarjian, MD (165 shared papers).
What insurance does Dr. William G. Wierda accept?
Dr. Wierda is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card